154 related articles for article (PubMed ID: 29337085)
1. DISC: Describing Infections of the Spine treated with Ceftaroline.
Watkins RR; Yendewa G; Burdette SD; Horattas S; Haller NA; Mangira C; Salata RA; Bonomo RA
J Glob Antimicrob Resist; 2018 Jun; 13():146-151. PubMed ID: 29337085
[TBL] [Abstract][Full Text] [Related]
2. The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.
Lin JC; Aung G; Thomas A; Jahng M; Johns S; Fierer J
J Infect Chemother; 2013 Feb; 19(1):42-9. PubMed ID: 22797874
[TBL] [Abstract][Full Text] [Related]
3. Ceftaroline fosamil for treatment of diabetic foot infections: the CAPTURE study experience.
Lipsky BA; Cannon CM; Ramani A; Jandourek A; Calmaggi A; Friedland HD; Goldstein EJ
Diabetes Metab Res Rev; 2015 May; 31(4):395-401. PubMed ID: 25417910
[TBL] [Abstract][Full Text] [Related]
4. Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series.
Lalikian K; Parsiani R; Won R; Chang E; Turner RB
J Chemother; 2018 Apr; 30(2):124-128. PubMed ID: 28697650
[TBL] [Abstract][Full Text] [Related]
5. Use of ceftaroline after glycopeptide failure to eradicate meticillin-resistant Staphylococcus aureus bacteraemia with elevated vancomycin minimum inhibitory concentrations.
Paladino JA; Jacobs DM; Shields RK; Taylor J; Bader J; Adelman MH; Wilton GJ; Crane JK; Schentag JJ
Int J Antimicrob Agents; 2014 Dec; 44(6):557-63. PubMed ID: 25282169
[TBL] [Abstract][Full Text] [Related]
6. Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience.
Johnson LB; Ramani A; Guervil DJ
BMC Infect Dis; 2019 Feb; 19(1):183. PubMed ID: 30791894
[TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.
Bucheit J; Collins R; Joshi P
Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602
[TBL] [Abstract][Full Text] [Related]
8. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis.
Jacqueline C; Amador G; Caillon J; Le Mabecque V; Batard E; Miègeville AF; Biek D; Ge Y; Potel G; Hamel A
J Antimicrob Chemother; 2010 Aug; 65(8):1749-52. PubMed ID: 20530506
[TBL] [Abstract][Full Text] [Related]
10. Methicillin-resistant Staphylococcus aureus nosocomial pneumonia patients treated with ceftaroline: retrospective case series of 10 patients.
Pasquale TR; Tan MJ; Trienski TL; File TM
J Chemother; 2015 Feb; 27(1):29-34. PubMed ID: 24621164
[TBL] [Abstract][Full Text] [Related]
11. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic pneumonia induced by ceftaroline.
Griffiths CL; Gutierrez KC; Pitt RD; Lovell RD
Am J Health Syst Pharm; 2014 Mar; 71(5):403-6. PubMed ID: 24534595
[TBL] [Abstract][Full Text] [Related]
13. Ceftaroline as Salvage Monotherapy for Persistent MRSA Bacteremia.
Burnett YJ; Echevarria K; Traugott KA
Ann Pharmacother; 2016 Dec; 50(12):1051-1059. PubMed ID: 27520326
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: case series and review of the literature.
Polenakovik HM; Pleiman CM
Int J Antimicrob Agents; 2013 Nov; 42(5):450-5. PubMed ID: 23993067
[TBL] [Abstract][Full Text] [Related]
15. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
[TBL] [Abstract][Full Text] [Related]
16. Integrated safety summary of CANVAS 1 and 2 trials: Phase III, randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections.
Corrado ML
J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv67-iv71. PubMed ID: 21115456
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of neutropenia in patients receiving prolonged treatment with ceftaroline.
Turner RB; Wilson DE; Saedi-Kwon H; Chang E; Won R; Chan D; Schwartz J
J Antimicrob Chemother; 2018 Mar; 73(3):772-778. PubMed ID: 29237024
[TBL] [Abstract][Full Text] [Related]
18. Ceftaroline-induced eosinophilic pneumonia.
Desai KR; Burdette SD; Polenakovik HM; Hagaman J; Pleiman CM
Pharmacotherapy; 2013 Jul; 33(7):e166-9. PubMed ID: 23649990
[TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
[TBL] [Abstract][Full Text] [Related]
20. Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
Branstetter J; Searcy H; Benner K; Yarbrough A; Crowder C; Troxler B
Pediatr Pulmonol; 2020 Dec; 55(12):3337-3342. PubMed ID: 32803907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
